References
- Rosen D. R. Mutations in the Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 364: 362
- Bruijn L. I., Miller T. M., Cleveland D. W. Unravelling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004; 27: 723–49
- Gurney M. E., Pu H., Chiu A. Y., Dal Canto M. C., Polchow C. Y., Alexander D. D., et al. Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science 1994; 264: 1772–5
- Kiaei M., Petri S., Kipiani K., Gardian G., Choi D. K., Chen J., et al. Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 2006; 26: 2467–73
- Beers D. R., Henkel J. S., Xiao Q., Zhao W., Wang J., Yen A. A., et al. Wild‐type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2006; 103: 16021–6
- Petri S., Kiaei M., Damiano M., Hiller A., Wille E., Manfredi G., et al. Cell‐permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. J Neurochem 2006; 98: 1141–8
- Durand J., Amendola J., Bories C., Lamotte d'Incamps B. Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis. J Physiol Paris 2006; 99: 211–20
- Weydt P., Hong S. Y., Kliot M., Moller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 2003; 14: 1051–4
- Miana‐Mena F. J., Munoz M. J., Yague G., Mendez M., Moreno M., Ciriza J., et al. Optimal methods to characterize the G93A mouse model of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2005; 6: 55–62
- Shefner J. M., Brown R. H., Jr., Cole D., Chaturvedi P., Schoenfeld D., Pastuszak K., et al. Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations. Neurology 2001; 57: 1857–61
- Shefner J. M., Cudkowicz M. E., Zhang H., Schoenfeld D., Jillapalli D. The use of statistical MUNE in a multicentre clinical trial. Muscle Nerve 2004; 30: 463–9
- Heiman‐Patterson T. D., Deitch J. S., Blankenhorn E. P., Erwin K. L., Perreault M. J., Alexander B. K., et al. Background and gender effects on survival in the TgN(SOD1‐G93A)1Gur mouse model of ALS. J Neurol Sci 2005; 236: 1–7
- Hemendinger R., Wang J., Malik S., Persinski R., Copeland J., Emerich D., et al. Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis. Exp Neurol 2005; 196: 235–43
- Shefner J. M., Cudkowicz M., Brown R. H., Jr. Motor unit number estimation predicts disease onset and survival in a transgenic mouse model of amyotrophic lateral sclerosis. Muscle Nerve 2006; 34: 603–7
- McHanwell S., Biscoe T. J. The sizes of motor neurons supplying hindlimb muscles in the mouse. Proc R Soc Lond B Biol Sci 1981; 213: 201–16
- Abmayr S., Weydt P. Skeletal muscle in amyotrophic lateral sclerosis: emerging concepts and therapeutic implications. Phys Med Rehabil Clin N Am 2005; 16: 1091–7
- Dobrowolny G., Giacinti C., Pelosi L., Nicoletti C., Winn N., Barberi L., et al. Muscle expression of a local Igf‐1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 2005; 168: 193–9
- Kennel P. F., Finiels F., Revah F., Mallet J. Neuromuscular function impairment is not caused by motor neuron loss in FALS mice: an electromyographic study. Neuroreport 1996; 7: 1427–31